These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 37277324

  • 21. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Tanabe P, Silva S, Bosworth HB, Crawford R, Paice JA, Richardson LD, Miller CN, Glassberg J.
    Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
    [Abstract] [Full Text] [Related]

  • 22. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
    Kato-Lin YC, Krishnamurti L, Padman R, Seltman HJ.
    Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
    [Abstract] [Full Text] [Related]

  • 23. Emergency Department Health Care Utilization and Opioid Administration Among Pediatric Patients With Sickle Cell Vasoocclusive Pain Crisis and Coexisting Mental Health Illness.
    Leuche VT, Cutler GJ, Nelson SC, Jin J, Bergmann KR.
    Pediatr Emerg Care; 2022 Feb 01; 38(2):e664-e669. PubMed ID: 33969978
    [Abstract] [Full Text] [Related]

  • 24. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H, Gupta M, Gupta K.
    Blood; 2017 Nov 30; 130(22):2377-2385. PubMed ID: 29187376
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
    Kavanagh PL, Sprinz PG, Wolfgang TL, Killius K, Champigny M, Sobota A, Dorfman D, Barry K, Miner R, Moses JM.
    Pediatrics; 2015 Oct 30; 136(4):e1016-25. PubMed ID: 26391933
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A comparison of the effect of patient-specific versus weight-based protocols to treat vaso-occlusive episodes in the emergency department.
    Tanabe P, Ibemere S, Pierce AE, Freiermuth CE, Bosworth HB, Yang H, Osunkwo I, Paxton JH, Strouse JJ, Miller J, Paice JA, Veeramreddy P, Kavanagh PL, Wilkerson RG, Hughes R, Barnhart HX.
    Acad Emerg Med; 2023 Dec 30; 30(12):1210-1222. PubMed ID: 37731093
    [Abstract] [Full Text] [Related]

  • 36. Characterization of opioid use in sickle cell disease.
    Han J, Zhou J, Saraf SL, Gordeuk VR, Calip GS.
    Pharmacoepidemiol Drug Saf; 2018 May 30; 27(5):479-486. PubMed ID: 28815799
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Exploring Emergency Department Provider Experiences With and Perceptions of Weight-Based Versus Individualized Vaso-Occlusive Treatment Protocols in Sickle Cell Disease.
    Knight LMJ, Onsomu EO, Bosworth HB, Crawford RD, DeMartino T, Glassberg J, Paice JA, Miller CN, Richardson L, Tanabe P.
    Adv Emerg Nurs J; 2019 May 30; 41(1):86-97. PubMed ID: 30702538
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.